Early-Onset Schizophrenia in a paediatric population of French psychiatric and medico-social care centres: A cross sectional study

Abstract

Background Early-Onset Schizophrenia (EOS) is rare but severe mental health disorder in children and adolescents. Diagnosis of schizophrenia before the age of 18 years remains complex and challenging, especially in young children. In France, there are no recent reliable epidemiological data about the prevalence of EOS. The present study evaluates the EOS rate in a target clinical population of children and adolescents in psychiatric and medico-social care centres in the SouthEast of France. Methods Psychiatric and medico-social centres for children and adolescent in the geographical area have been contacted, and after receiving their agreement to participate in the study, eligible patients corresponding to inclusion criteria were selected based on patients' medical records. Main inclusion criteria were age 7 to 17 years and intelligence quotient > 35. EOS categorical diagnosis was assessed by Kiddie-SADS Present and Lifetime psychosis section. Results 37 centres participated and 302 subjects have been included in the study. The main result was the categorical diagnosis of EOS in 27 subjects, corresponding to a rate of 8.9% in the study population. Half of the patients presented mild to moderate intellectual deficiency. Interestingly, only 2.3% had a diagnosis of schizophrenia spectrum disorder noted in their medical records before standardized assessment.

National record-linkage study of hospital admissions for schizophrenia in childhood and adolescence in England

“…Clinical surveys have limitations—notably, sampling bias and non-standardised diagnosis. Indeed, recent work suggests that not using standardised interviews leads to an underestimate of the rates of early-onset schizophrenia, especially in cases with intellectual disability and neurodevelopmental disorders [ 22 ]. The validity of Hospital Episode Statistics for identifying cases of schizophrenia in adults is high, with positive predictive value of 90% [ 23 ].…”

A novel microduplication in INPP5A segregates with schizophrenia spectrum disorder in the family of a patient with both childhood onset schizophrenia and autism spectrum disorder

“…GenAuDiss is a translational multicentric study (NCT02565524). Patients with COS or Early‐Onset‐Schizophrenia (EOS) (with symptoms occurring before the age of 18) were initially recruited through the 2011–2013 Interregional Hospital Clinical Research Program (NCT01512641) whose main goal was to estimate the prevalence of COS and EOS in a population of children and adolescents in child psychiatry care or medical‐educational structures (Dor‐Nedonsel et al, 2020; Fernandez et al, 2018). In addition, an enrolment in the present study is offered to inpatients and outpatients of Child and Adolescent Psychiatry (CAP) centers, as well as their first‐degree relatives.…”

A Pilot Study on Early-Onset Schizophrenia Reveals the Implication of Wnt, Cadherin and Cholecystokinin Receptor Signaling in Its Pathophysiology

“…The main goal of this program was to estimate the prevalence of EOS in a population of children in child psychiatric care or medicoeducational structures (Dor-Nedonsel et al, 2020). In addition, an enrolment in the GenAuDiss protocol (NCT02565524) study was offered to in-and out-patients, to Child and Adolescent Psychiatry (CAP) centers, and to their first-degree relatives (Fernandez et al, 2018).…”